poloxamer
英
美
网络 聚羟体; 泊洛沙姆; 泊咯沙姆; 泊罗沙; 泊罗沙姆
双语例句
- Advances of poloxamer 407 in situ gel used as drug carrier
泊洛沙姆407原位凝胶作为药物载体的研究进展 - Paclitaxel-loaded poly(ε-caprolactone)/ poloxamer 188 nanoparticles and its antitumor activity
紫杉醇聚己内酯/泊洛沙姆188载药纳米粒及其抗肿瘤活性 - Progress of Poloxamer 407 in pharmaceutics
泊洛沙姆407在制剂中的应用进展 - Adjuvant chemotherapy; Acute Toxicity Test of a New Pharmaceutical Adjuvant ─ Poloxamer 407
新辅助化疗；辅助化疗；新型药用辅料&泊洛沙姆407急性毒性初步研究 - METHODS The intravenous emulsions were prepared using injectable egg yolk phospholipids and non-ionic emulsifier poloxamer 188 as cosurfactant.
方法用可静脉注射用的蛋黄磷脂和泊洛沙姆188，制备出人参皂苷Rh2静脉乳剂。 - S: AIM To prepare solid dispersions of ciclosporin ( CsA) with poloxamer 188 ( F68) and examine the dissolution properties of CsA from this system.
目的以泊洛沙姆188（F68）为载体制备环孢素（CsA）固体分散体并考察其体外溶出。 - CONCLUSION The low concentrations of sodium deoxycholate and poloxamer 188 may be effective ophthalmic penetration enhancers with less irritancy.
结论低浓度的去氧胆酸钠和泊洛沙姆188为刺激性小、有效的眼用渗透促进剂。 - Poloxamer 188 can also inhibit inflammation and resist thrombus.
泊洛沙姆188具有抑制炎症和抗血栓形成作用，注射使用具有一定的安全性； - Results: In PVP silibinin solid dispersions drug was amorphous; in poloxamer 188 silibinin solid dispersions, drug existed as fine crystal, while in urea silibinin solid dispersions most of silibinin existed as crystal, only a little as molecule.
结果：水飞蓟宾在PVP中以无定型存在，在泊洛沙姆188中以微细结晶存在，在尿素中大部分仍以晶体形式存在，少量以分子状态存在。 - Synthesis and in situ gelling properties of acrylic acid-poloxamer 407 copolymers
丙烯酸-泊洛沙姆407共聚物的合成及其原位胶凝性质 - Application of Poloxamer in Pharmaceutics
泊洛沙姆在药剂学中的应用 - Sustained release of fluorofur in vitro from poloxamer 407 gel matrices
喃氟啶从Poloxamer407凝胶基质中的体外释放 - As a safe excipient, poloxamer 188 is often used as solubilizing agent, emulsifying agent and gene carrier in injection.
在注射给药方面，泊洛沙姆188可作为增溶剂、乳化剂以及基因药物的载体。 - An injectable excipient: poloxamer 188
注射用辅料泊洛沙姆188 - Measurement of~ ( 237) Th half-life Application of Poloxamer in Pharmaceutics
~（237）Th的半衰期测量泊洛沙姆在药剂学中的应用 - The application of poloxamer in pharmaceutics used as additives or substrates in tablets, solid lipid nanoparticles, suppositories, controlled release gels, ophthalmic delivery system was summarized.
从片剂、固体脂质纳米粒系统、栓剂、控释水凝胶、长循环微粒制剂、眼部给药系统等7个方面，介绍了近年来泊洛沙姆在药剂学领域中的应用。 - Dynamic changes of a new pharmaceutical adjuvant& poloxamer 407 gel injected into the livers of rabbits
新型药用辅料&泊洛沙姆407兔肝内注射后的动态变化 - Method P ( MAA co poloxamer) copolymer hydrogels were synthesized and the gel swelling, solute diffusivity and drug release properties were investigated in different pH media.
方法制备了聚（甲基丙烯酸泊洛沙姆）共聚物水凝胶；在不同pH值的介质中研究凝胶溶胀、药物扩散和药物释放性质； - Objective: To determine the therapeutic effects of Norcantharidin Poloxamer 407 in intratumoral administration to primary liver cancer.
目的：探讨去甲斑蝥素泊洛沙姆407缓释制剂局部注射治疗肝癌的疗效。 - Methods DSP-loaded thermosensitive in situ gel was prepared by using poloxamer 407 as matrix.
方法制备DSP温度敏感原位凝胶。 - Objective To synthesize copolymers composed of polyacrylic acid and poloxamer 407, and investigate its thermo-sensitive gelling properties in situ.
目的制备丙烯酸和泊洛沙姆407构成的共聚物，研究其温度敏感的原位胶凝性质。 - In vitro evaluation of solid dispersions of ciclosporin with poloxamer 188
环孢素-泊洛沙姆188固体分散体的体外评价 - Preparation of cross-linked poloxamer hydrogel spheres in an aqueous two-phase system
双水相中制备交联泊洛沙姆亲水凝胶微球 - The reversible gelation behaviors of poloxamer 407 ( P407) solutions showed strong concentration dependency.
经相变温度和粘度的测定，泊洛沙姆407溶液的可逆胶凝行为呈现强烈的浓度依赖性，泊洛沙姆188可调节相变温度，氯化钠可降低相变温度。 - Correlation analysis demonstrated that drug release, which followed zero-order kinetics, from poloxamer gel was completely controlled by gel erosion.
结果显示二者均遵循零级动力学过程，且泊洛沙姆凝胶中药物的释放受溶蚀控制。 - Experimental factors, such as release area and shaking frequency, and formulation factors, such as poloxamer composition, influenced the rate of gel erosion and drug release.
实验因素（释放面积和震荡频率）与处方因素（泊洛沙姆的组成）可影响凝胶溶蚀与药物释放速率。 - In this study, a thermo-sensitive polymer ( poloxamer) was introduced into ocular delivery system, which made preparations free-pouring liquid at room temperature and semi-solid gel after administration under body temperature.
本研究将温敏型高分子材料泊洛沙姆引入眼部给药系统，可以使眼用制剂在室温下呈自由流动的液体，给药后形成半固体凝胶。 - Had umbilical Point to transdermal drug delivery technology of preparation of the molding; respectively peony extract, Corydalis Yan Shao extract and extract compound as the main drug of polyethylene glycol and poloxamer preparations for the matrix the maximum drug loading were investigated.
进行了脐中穴经皮给药制剂的成型工艺研究；分别以白芍提取物、延胡索提取物和延芍复方制剂提取物作为主药，对以聚乙二醇和泊洛沙姆为基质的制剂的最大载药量进行了考察。 - Poloxamer 407, a thermosensitive high molecular material, was introduced into nasal drug delivery system. This material can make the nasal preparation liquid state at room temperature and a semisolid gel at nasal temperature ( 33 ℃).
将热敏性高分子材料泊洛沙姆407引入鼻腔给药系统，可以使鼻用制剂在室温下为自由流动的液体，给药后在鼻腔温度（33℃）下形成半固体凝胶。